Linkage studies identify regions of the genome that are shared more frequently than would be expected by chance by relatives affected by a particular disease. Most studies analyze affected sibling pairs and utilize genetic markers that are scattered throughout the genome at moderate density, typically microsatellites. A significant excess of allele sharing identical by-descent (IBD) in affected sibpairs suggests that the region containing the marker locus also contains a disease susceptibility locus. The first linkage scan for T1DM identified 20 chromosomal regions with suggestive evidence of linkage to disease, including the HLA and INS gene regions.
Read More »Jeffrey Emmick 2018 Transcript
In this Exclusive Interview, Jeffrey Emmick talks with Diabetes in Control during the ADA 2018 convention about Lilly diabetes products in the pipeline.
Read More »Jeffrey Emmick 2018 Full Interview
In this Exclusive Interview, Jeffrey Emmick talks with Diabetes in Control Medical Editor Joy Pape (with a special appearance by Diabetes In Control Publisher Steve Freed) during the ADA 2018 convention in Orlando about Lilly's diabetes products in the pipeline.
Read More »Jeffrey Emmick Part 1, Lilly Diabetes New Research
In part 1 of this Exclusive Interview, Jeffrey Emmick talks with Diabetes in Control Medical Editor Joy Pape about various products Lilly has brought to market and new products in development.
Read More »Jeffrey Emmick Part 2, Lilly Studies Combining GLP1 and SGLT2 Inhibitors
In part 2 of this Exclusive Interview, Jeffrey Emmick talks with Diabetes in Control Medical Editor Joy Pape about the combination of GLP1s and SGLTs while Diabetes in Control Publisher Steve Freed makes a quick appearance to ask about the possible effects of their combined use.
Read More »Association Between Elevated Heart Rate and Type 2 Diabetes
Increased heart rate in people with CAD has shown to increase diagnosis risk despite BMI and blood pressure.
Read More »The ARB Recall: What Really Happened
FDA examines solvent used in production process.
Read More »Long-Term Type 1 Diabetes Associated with Undiagnosed CAD
Higher prevalence of heart disease studied in older people who have type 1.
Read More »Consider More Accountability as a Treatment for Some Patients
Male, 57 years of age, type 2 diabetes. He started with us 6 months ago. When he started seeing us, he was taking glipizide 10mg twice a day and metformin 1,000 twice daily for his glucose. His A1C was 7.5%, his BMI was 24. We stopped his glipizide and started him on a SGLT-2 and a weekly GLP-1. He met with the dietitian and made some big dietary changes, at least at the start. He also started wearing a CGM and was in our remote monitoring program. He sent me his CGM readings weekly for 4 months. He was doing so well, we decided he need not send me his weekly numbers but rather we’d review during his visits.
Read More »Tim Dunn 2018 Complete Interview
Tim Dunn, Ph.D., is the director of Clinical and Computational Research and an Abbott Volwiler Research Fellow. He also serves as Chair of the Scientific Research Review Committee for investigator-initiated studies. His major areas of expertise are clinical trial strategy and trial design and real-world data analysis.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.